Icon

TYBOST (nda203094)- (150MG)

COBICISTAT GILEAD SCIENCES INC
150MG
Yes No
2033-Apr-06 2017-Aug-27
None 2017-Sep-24
None No
TYBOST is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection in adults and in pediatric patients: • weighing at least 35 kg co-administered with atazanavir or • weighing at least 40 kg co-administered with darunavir.
1 0 0
Total Other Developers 1
Drugs with Suitability No
150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.